FORM 6-K
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 under
the
Securities Exchange Act of 1934
For the month ended
July, 2012
ICON plc
(Registrant's
name)
0-29714
(Commission file number)
South
County Business Park, Leopardstown, Dublin 18, Ireland
(Address of
principal executive offices)
Brendan Brennan, CFO
South County
Business Park Leopardstown, Dublin 18, Ireland.
Brendan.Brennan@iconplc.com
0011-353-1-291-2000
(Name,
telephone number, email and/or facsmile number and address of Company
contact person)
Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.
Yes___X___ No_______
Indicate by check mark whether the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes______ No___X___
Indicate by check mark whether the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes______ No___X___
Indicate by check mark whether the registrant by furnishing the
information contained in this Form is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the
Securities Exchange Act of 1934.
Yes_______ No___X___
If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2(b):82 N/A
EXHIBIT LIST
|
Exhibit |
Description |
||
|
99.1 |
Icon plc Press Release announcement issued July 20, 2012. |
||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
ICON plc |
||
|
|
||
| Date: |
July 20, 2012 |
/s/ Brendan Brennan |
|
Brendan Brennan |
||
|
Chief Financial Officer |
Exhibit 99.1
ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
DUBLIN--(BUSINESS WIRE)--July 20, 2012--ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that all resolutions recommended by the Board at the Annual General Meeting of the Company held on 19 July 2012 were duly passed by shareholders. These resolutions were set out in the Notice of the Annual General Meeting sent to shareholders on 12 June 2012 and are available on the ICON plc website www.iconplc.com.
DISCLOSURE NOTICE: The information contained in this release is as of July 20th, 2012. ICON assumes no obligation to update forward-looking statements contained in this release. A description of risks and uncertainties relating to ICON and its business can be found in ICON’s Annual Report and Form 20-F for the fiscal year ended December 31, 2011 and in its Reports of Foreign Issuer on Form 6-K filed with the US Securities and Exchange Commission.
About ICON plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 8,930 employees, operating from 83 locations in 40 countries.
Further information is available at www.iconplc.com
Source: ICON plc
ICON/ICLR-F
CONTACT:
Contact:
Investor Relations
1-888-381-7923
or
Brendan
Brennan
Chief Financial Officer
+ 353 –1-291-2000
or
Sam
Farthing
VP Investor Relations
+ 353 –1-291-2000
All at
ICON.